A rare medical condition associated with pregnancy, known as atypical hemolytic uremic syndrome (aHUS), has shown that kidney recovery is possible even with delayed treatment. This condition, characterized by the triad of anemia, low platelet count, and acute kidney injury, typically occurs in the later stages of pregnancy or after childbirth. A recent case involves a 29-year-old first-time mother who, at 33 weeks pregnant, was diagnosed with severe kidney issues, thrombocytopenia, and anemia.
The patient, who presented with facial swelling and high blood pressure, required urgent medical interventions, including hemodialysis and a cesarean section. Despite the urgency, her kidney function remained impaired after childbirth, necessitating continued dialysis. Genetic testing revealed a mutation in the complement factor H, confirming the diagnosis of aHUS.
Initially, treatment with eculizumab, a drug that inhibits the complement system, was delayed. However, once initiated, and later switched to ravulizumab, the patient’s kidney function improved significantly, allowing her to become dialysis-independent within five weeks. This case underscores the importance of considering aHUS as a diagnosis in pregnant patients with severe renal issues and demonstrates that meaningful recovery is achievable even with postponed treatment.
aHUS, a condition driven by complement system dysregulation, is distinct from other similar conditions due to its genetic underpinnings. It poses a diagnostic challenge, often confused with other pregnancy-related disorders like HELLP syndrome. However, when kidney dysfunction is severe and not aligned with liver enzyme levels, aHUS should be suspected. The case highlights the potential for recovery even when treatment is not immediate, offering hope for those affected by this rare condition.
